Cantor Fitzgerald Weighs in on Teladoc Health FY2025 Earnings

Teladoc Health, Inc. (NYSE:TDOC - Free Report) - Cantor Fitzgerald issued their FY2025 earnings per share estimates for Teladoc Health in a research report issued to clients and investors on Thursday, February 27th. Cantor Fitzgerald analyst S. James anticipates that the health services provider will post earnings of ($0.78) per share for the year. The consensus estimate for Teladoc Health's current full-year earnings is ($1.16) per share.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The company had revenue of $640.49 million during the quarter, compared to analysts' expectations of $639.44 million.

TDOC has been the topic of a number of other reports. Oppenheimer decreased their target price on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a report on Friday, January 24th. Piper Sandler dropped their price target on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research note on Thursday, February 27th. The Goldman Sachs Group decreased their target price on Teladoc Health from $16.00 to $13.00 and set a "buy" rating on the stock in a research report on Monday. Bank of America raised their target price on Teladoc Health from $11.50 to $13.50 and gave the stock a "neutral" rating in a research note on Wednesday, February 12th. Finally, Royal Bank of Canada raised their price objective on shares of Teladoc Health from $11.00 to $12.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Eleven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, Teladoc Health presently has a consensus rating of "Hold" and a consensus price target of $11.26.

Remove Ads

Teladoc Health Stock Down 1.8 %

Shares of TDOC traded down $0.17 during mid-day trading on Monday, reaching $9.23. The company had a trading volume of 3,535,405 shares, compared to its average volume of 8,355,221. The firm has a 50-day moving average price of $10.62 and a 200 day moving average price of $9.62. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The company has a market capitalization of $1.60 billion, a price-to-earnings ratio of -1.60 and a beta of 1.27. Teladoc Health has a 52 week low of $6.76 and a 52 week high of $15.95.

Hedge Funds Weigh In On Teladoc Health

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Arizona State Retirement System grew its stake in Teladoc Health by 1.8% during the 4th quarter. Arizona State Retirement System now owns 49,691 shares of the health services provider's stock valued at $452,000 after acquiring an additional 859 shares in the last quarter. Mercer Global Advisors Inc. ADV increased its stake in shares of Teladoc Health by 9.6% during the fourth quarter. Mercer Global Advisors Inc. ADV now owns 12,456 shares of the health services provider's stock worth $113,000 after buying an additional 1,089 shares during the period. Canada Pension Plan Investment Board increased its holdings in Teladoc Health by 0.5% in the fourth quarter. Canada Pension Plan Investment Board now owns 228,700 shares of the health services provider's stock valued at $2,079,000 after buying an additional 1,200 shares during the last quarter. Summit Investment Advisors Inc. boosted its holdings in Teladoc Health by 8.0% in the fourth quarter. Summit Investment Advisors Inc. now owns 18,009 shares of the health services provider's stock valued at $164,000 after purchasing an additional 1,331 shares in the last quarter. Finally, Vise Technologies Inc. lifted its position in Teladoc Health by 4.9% in the fourth quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider's stock valued at $274,000 after acquiring an additional 1,405 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.